Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW842470X in moderate atopic dermatitis
NCT00354510Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GW842470X in atopic dermatitis (AD), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
GW842470X
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00354510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354510.